Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
West Indian med. j ; 53(5): 359-362, Oct. 2004.
Article in English | LILACS | ID: lil-410230

ABSTRACT

Children infected with HIV display great variability in their clinical outcome and rate of progression to AIDS. The reasons for this variability are largely unknown. Increasing evidence from adult studies suggests that the cellular immune response is a critical determinant of viral containment, and likely accounts for much of the observed variability in clinical progression. Detailed studies of the HIV-specific immune responses generated by adults with long-term nonprogressive infection have revealed elements of the host immune response that correlate with effective viral control. However, much less is known about the HIV-specific immune responses generated by perinatally infected children. Recent studies have revealed that elements of both the HIV-specific cytotoxic T lymphocyte response (mediated by CD8+ lymphocytes) and the T-helper response (mediated by CD4+ lymphocytes) differ between adults and children, and these differences could have important implications for the ability to control HIV viraemia. Identification of the precise correlates of viral containment in children could provide important insights into the pathogenesis of vertical infection, and will greatly assist the rational design of HIV vaccines and immunotherapies


Subject(s)
Humans , Infant, Newborn , Infant , Child, Preschool , Child , HIV Infections/immunology , Immune System/growth & development , HIV-1 , Disease Progression , HIV Infections/physiopathology , /immunology , T-Lymphocytes, Cytotoxic/immunology , Acquired Immunodeficiency Syndrome/immunology , Acquired Immunodeficiency Syndrome/physiopathology
2.
J Virol ; 78(16): 8927-30, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15280502

ABSTRACT

The emergence of cytotoxic T-lymphocyte (CTL) escape mutations in human immunodeficiency virus type 1 (HIV-1) proteins has been anecdotally associated with progression to AIDS, but it has been difficult to determine whether viral mutation is the cause or the result of increased viral replication. Here we describe a perinatally HIV-infected child who maintained a plasma viral load of <400 copies/ml for almost a decade until a nonbinding escape mutation emerged within the immunodominant CTL epitope. The child subsequently experienced a reemergence of HIV-1 viremia accompanied by a marked increase in the number of CTL epitopes targeted. This temporal pattern suggests that CD8 escape can play a causal role in the loss of immune control.


Subject(s)
HIV Infections/immunology , HIV Long-Term Survivors , HIV-1/immunology , T-Lymphocytes, Cytotoxic/immunology , Amino Acid Sequence , Child , Disease Progression , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/genetics , HIV Infections/virology , HIV-1/genetics , HLA-B27 Antigen/metabolism , Humans , Immunodominant Epitopes/chemistry , Immunodominant Epitopes/genetics , Molecular Sequence Data , Mutation , Viremia/immunology , Viremia/virology
3.
J Virol ; 78(5): 2187-200, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14963115

ABSTRACT

Although there is increasing evidence that virus-specific cytotoxic-T-lymphocyte (CTL) responses play an important role in the control of human immunodeficiency virus (HIV) replication in vivo, only scarce CTL data are available for the ethnic populations currently most affected by the epidemic. In this study, we examined the CD8(+)-T-cell responses in African-American, Caucasian, Hispanic, and Caribbean populations in which clade B virus dominates and analyzed the potential factors influencing immune recognition. Total HIV-specific CD8(+)-T-cell responses were determined by enzyme-linked immunospot assays in 150 HIV-infected individuals by using a clade B consensus sequence peptide set spanning all HIV proteins. A total of 88% of the 410 tested peptides were recognized, and Nef- and Gag-specific responses dominated the total response for each ethnicity in terms of both breadth and magnitude. Three dominantly targeted regions within these proteins that were recognized by >90% of individuals in each ethnicity were identified. Overall, the total breadth and magnitude of CD8(+)-T-cell responses correlated with individuals' CD4 counts but not with viral loads. The frequency of recognition for each peptide was highly correlated with the relative conservation of the peptide sequence, the presence of predicted immunoproteasomal cleavage sites within the C-terminal half of the peptide, and a reduced frequency of amino acids that impair binding of optimal epitopes to the restricting class I molecules. The present study thus identifies factors that contribute to the immunogenicity of these highly targeted and relatively conserved sequences in HIV that may represent promising vaccine candidates for ethnically heterogeneous populations.


Subject(s)
Ethnicity , HIV Antigens/immunology , HIV/immunology , Immunodominant Epitopes/immunology , T-Lymphocytes, Cytotoxic/immunology , AIDS Vaccines , Black or African American/genetics , Amino Acid Sequence , Anti-Retroviral Agents/pharmacology , CD4 Lymphocyte Count , Cells, Cultured , Entropy , Ethnicity/genetics , Gene Frequency , HIV/chemistry , HIV/drug effects , HIV Antigens/chemistry , Hispanic or Latino/genetics , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/immunology , Humans , Immunodominant Epitopes/chemistry , Molecular Sequence Data , Viral Load
4.
West Indian Med J ; 53(5): 359-62, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15675505

ABSTRACT

Children infected with HIV display great variability in their clinical outcome and rate of progression to AIDS. The reasons for this variability are largely unknown. Increasing evidence from adult studies suggests that the cellular immune response is a critical determinant of viral containment, and likely accounts for much of the observed variability in clinical progression. Detailed studies of the HIV-specific immune responses generated by adults with long-term nonprogressive infection have revealed elements of the host immune response that correlate with effective viral control. However, much less is known about the HIV-specific immune responses generated by perinatally infected children. Recent studies have revealed that elements of both the HIV-specific cytotoxic T lymphocyte response (mediated by CD8+ lymphocytes) and the T-helper response (mediated by CD4+ lymphocytes) differ between adults and children, and these differences could have important implications for the ability to control HIV viraemia. Identification of the precise correlates of viral containment in children could provide important insights into the pathogenesis of vertical infection, and will greatly assist the rational design of HIV vaccines and immunotherapies.


Subject(s)
HIV Infections/immunology , Immune System/growth & development , Acquired Immunodeficiency Syndrome/immunology , Acquired Immunodeficiency Syndrome/physiopathology , CD4-Positive T-Lymphocytes/immunology , Child , Child, Preschool , Disease Progression , HIV Infections/physiopathology , HIV-1/immunology , Humans , Infant , Infant, Newborn , T-Lymphocytes, Cytotoxic/immunology
5.
J Virol ; 77(13): 7492-501, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12805449

ABSTRACT

Advances in antiviral therapy have dramatically shifted the demographics of pediatric human immunodeficiency virus type 1 (HIV-1) infection in the developed world, and a growing proportion of perinatally HIV-1-infected children are now entering their second or even third decade of life. Although cellular immune responses to HIV are known to be weak in early infancy, the magnitude, breadth, and specificity of responses later in childhood have not been characterized in detail. We performed a comprehensive characterization of HIV-1-specific CD8 responses in 18 perinatally infected children (age range, 6 to 17 years), most of whom were on antiviral therapy, using both previously defined HIV-1 epitopes and overlapping peptides spanning all HIV-1 proteins. Multispecific responses were detected in all subjects and accounted for a median of 0.25 to 0.3% of all peripheral blood mononuclear cells that was similar to the magnitude seen in HIV-infected adults. CD8 responses were broadly directed at an average of 11 epitopes (range, 2 to 27 epitopes) and targeted nearly all HIV-1 proteins, with the highest proportion in Gag. Responses were readily detected even in those children with suppressed viremia on highly active antiretroviral therapy, although the breadth (P = 0.037) and the magnitude (P = 0.021) were significantly lower in these subjects. Each child recognized only a small minority of the HIV-1 optimal epitopes defined for his or her class I HLA alleles. Together, these data indicate that perinatally infected children who survive infancy mount a robust HIV-1-specific CD8 response that is much stronger than previously thought and is comparable in magnitude and breadth to that of adults. Moreover, this response has the potential to be broadened to target more epitopes, making these children attractive candidates for immunotherapeutic interventions.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , Infectious Disease Transmission, Vertical , Adolescent , Amino Acid Sequence , Base Sequence , Child , DNA Primers , Epitopes/chemistry , Epitopes/immunology , Female , HIV Infections/transmission , HIV-1/immunology , HIV-1/isolation & purification , Humans , Male , Molecular Sequence Data , Viremia/immunology
6.
J Virol ; 77(3): 2081-92, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12525643

ABSTRACT

Cellular immune responses play a critical role in the control of human immunodeficiency virus type 1 (HIV-1); however, the breadth of these responses at the single-epitope level has not been comprehensively assessed. We therefore screened peripheral blood mononuclear cells (PBMC) from 57 individuals at different stages of HIV-1 infection for virus-specific T-cell responses using a matrix of 504 overlapping peptides spanning all expressed HIV-1 proteins in a gamma interferon-enzyme-linked immunospot (Elispot) assay. HIV-1-specific T-cell responses were detectable in all study subjects, with a median of 14 individual epitopic regions targeted per person (range, 2 to 42), and all 14 HIV-1 protein subunits were recognized. HIV-1 p24-Gag and Nef contained the highest epitope density and were also the most frequently recognized HIV-1 proteins. The total magnitude of the HIV-1-specific response ranged from 280 to 25,860 spot-forming cells (SFC)/10(6) PBMC (median, 4,245) among all study participants. However, the number of epitopic regions targeted, the protein subunits recognized, and the total magnitude of HIV-1-specific responses varied significantly among the tested individuals, with the strongest and broadest responses detectable in individuals with untreated chronic HIV-1 infection. Neither the breadth nor the magnitude of the total HIV-1-specific CD8+-T-cell responses correlated with plasma viral load. We conclude that a peptide matrix-based Elispot assay allows for rapid, sensitive, specific, and efficient assessment of cellular immune responses directed against the entire expressed HIV-1 genome. These data also suggest that the impact of T-cell responses on control of viral replication cannot be explained by the mere quantification of the magnitude and breadth of the CD8+-T-cell response, even if a comprehensive pan-genome screening approach is applied.


Subject(s)
Acquired Immunodeficiency Syndrome/immunology , Genome, Viral , HIV-1/immunology , T-Lymphocytes/immunology , Acquired Immunodeficiency Syndrome/virology , Amino Acid Sequence , Epitopes, T-Lymphocyte , Female , Gene Products, nef/immunology , HIV Core Protein p24/immunology , Humans , Interferon-gamma/biosynthesis , Male , Molecular Sequence Data , Peptide Fragments/immunology , Viral Load , nef Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...